"I applaud Duane Morris for its recent (and ongoing) efforts in representing Actavis in an Abbreviated New Drug Application (ANDA) patent infringement trial held in district court in New Jersey. The trial involved an Actavis generic drug product which was accused of infringing certain patents. The effort put forth by both the professional and support staff at Duane Morris was outstanding. The Duane Morris team faced a daunting challenge as it was substituted in as counsel only months before trial. However, Duane Morris attorneys and support staff worked tirelessly to learn the case and were able to quickly provide legal analysis and guidance. I was especially impressed in how the team pulled in the right attorneys from various Duane Morris offices in Boston, New Jersey and Washington, and the appropriate staffing of the case resulted in significant cost savings to Actavis. The substantive performance of the attorneys at trial was excellent. Despite obstacles we faced from opposing counsel, the Duane Morris team was not thrown off its game. The management of trial logistics was such that I now consider it a model to be followed in any patent infringement lawsuit in which Actavis is involved. I was and am proud to have Duane Morris represent Actavis. Duane Morris is at the top of my list when selecting law firms to represent Actavis in future matters."

JIM MAHANNA
Director, IP
Actavis

Attorneys at Duane Morris specialize in the representation of worldwide generic pharmaceutical companies bringing products to the U.S. markets.

Chambers USA 2012 on Duane Morris' IP capabilities in the Pharmaceutical Industry:

"This firm's dedicated team handles the spectrum of IP matters including national litigation, clearance and registration [and] complex technological issues, particularly involving biometric technology and pharmaceutical IP in patent and noncompetition matters."

"Wockhardt Limited (including its global collection of affiliates and subsidiaries) is committed to serving the global healthcare marketplace with high-quality pharmaceutical products and treatment solutions. We have a strong and growing presence in generic and innovative pharmaceuticals, biopharmaceuticals and other products throughout the world. During our product development stages, and with an eye toward potential marketing of approved pharmaceutical products in the United States, we frequently rely upon the counsel of experienced lawyers who have significant expertise in, amongst other things, pharmaceutical regulatory compliance, Hatch-Waxman litigation matters, issues of inventorship and opinion letters. It is imperative, however, that this professional expertise is coupled with a keen understanding of our business needs, while being supported by a strong scientific and technical foundation. I am proud to say that our team at Duane Morris understands our business culture. They consistently provide the best customer service and cost-effective high quality work. The best part of working with the Duane Morris team is that they understand the commercial aspects of Wockhardt in the USA."

DR. MANDAR M. KODGULE
Vice President, Head of Global Intellectual Property & Strategic Planning
Wockhardt Limited